VIVIAN KLANN: Open Payments
NPI 1023316619 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 7 payments from 6 companies in 2025. Trend: 2023 $1,054 · 2024 $1,893 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| ABBVIE INC. | 2 | $49 |
| Exelixis Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $16 |
Products named: Pemazyre, ENHERTU, CABOMETYX, IMBRUVICA, SCEMBLIX, EPKINLY, VERZENIO.
Industry payments across CA — which companies pay providers there.
